Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Henry Khederian

Why Evofem Biosciences Shares Are Getting Hammered Today

Evofem Biosciences Inc (NASDAQ:EVFM) shares are trading lower by 59.76% at $0.44 after the company announced the pricing of a roughly $26.6 million public offering.

Evofem says the company intends to use the net proceeds from the offering for the continuation of commercialization activities related to its commercial product, Phexxi®. The offering is expected to close on or about May 24, 2022, subject to satisfaction of customary closing conditions.

See Also: Why Nio Shares Are Rising Today

Evofem Biosciences Inc is a commercial-stage biopharmaceutical company.

According to data from Benzinga Pro, Evofem Biosciences has a 52-week high of $21.30 and a 52-week low of $0.43.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.